VERACYTE, INC. CHANGE OF CONTROL AND SEVERANCE AGREEMENTChange of Control and Severance Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Change of Control and Severance Agreement (the “Agreement”) is made and entered into by and between Bonnie Anderson (“Executive”) and Veracyte, Inc., a Delaware corporation (the “Company”), effective as of August 24, 2012 (the “Effective Date”).
ContractWarrant Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
PATHOLOGY SERVICES AGREEMENTPathology Services Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • Texas
This Business Associate Agreement (the “Agreement”) is made by and among VERACYTE, INC., a California corporation (herein referred to as “Covered Entity”) and BRAZOS VALLEY PATHOLOGY, P.A. D/B/A REITPATH, a Texas professional association (hereinafter referred to as “Business Associate”). Covered Entity and Business Associate shall be collectively referred to herein as the “Parties”.
LEASE AGREEMENTLease Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
THIS LEASE AGREEMENT (this “Lease”) is made as of this 10 day of February, 2010 (the “Lease Date”), between ARE-SAN FRANCISCO NO. 17, LLC, a Delaware limited liability company (“Landlord”), and VERACYTE, INC., a Delaware corporation (“Tenant”).
LEASE AGREEMENT BETWEEN RIATA HOLDINGS, L.P., AS LANDLORD, AND VERACYTE, INC., AS TENANT DATED NOVEMBER 28, 2012 RIATA CORPORATE PARK 12357 A RIATA TRACE PARKWAY, BUILDING 5 AUSTIN, TEXAS 78727Lease Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • Texas
This Lease Agreement (this “Lease”) is entered into as of the Lease Date between Landlord and Tenant (as each such term is defined in the Basic Lease Information).
CO-PROMOTION AGREEMENTCo-Promotion Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • New York
Genzyme Corporation, with offices located at 500 Kendall Street, Cambridge, Massachusetts 02142 (hereinafter referred to as “Genzyme”)
VERACYTE, INC. AMENDMENT TO BONNIE ANDERSON EMPLOYMENT AGREEMENTAmendment to Employment Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Amendment to the Bonnie Anderson Employment Agreement (the “Amendment’’) is made as of December [22], 2008, by and between Veracyte, Inc. (formerly known as Calderome, Inc.) (the “Company”), and Bonnie Anderson (the “Executive”).
FIRST AMENDMENT TO PATHOLOGY SERVICES AGREEMENTPathology Services Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
THIS FIRST AMENDMENT TO PATHOLOGY SERVICES AGREEMENT (the “Amendment”) is made and entered into as of December 19, 2012, by and between VERACYTE, INC., a California corporation (“Veracyte”) and THYROID CYTOLOGY PARTNERS, P.A., a Texas professional association (“Pathologists”) with respect to the following:
VERACYTE, INC. AMENDMENT NO. 2 TO BONNIE ANDERSON EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Amendment No. 2 to the Bonnie Anderson Employment Agreement (the “Amendment”) is effective as of March 11, 2009, by and between Veracyte, Inc. (formerly known as Calderome, Inc.) (the “Company”), and Bonnie Anderson (the “Executive”).
VERACYTE, INC. AMENDMENT TO SECOND AMENDED AND RESTATED INVESTOR RIGHTS’ AGREEMENTInvestor Rights Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
This Amendment to Second Amended and Restated Investors’ Rights Agreement (this “Amendment”) is entered and effective as of June 14, 2013, by and among Veracyte, Inc., a Delaware corporation (the “Company”), and the undersigned stockholders of the Company’s issued and outstanding Preferred Stock (the “Stockholders”).
CALDEROME, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • California
This Agreement is entered into as of February 15, 2008, (the “Effective Date”) by and between Calderome, Inc., a Delaware corporation (the “Company”), and Bonnie Anderson (“Executive”).
LOAN AND SECURITY AGREEMENTLoan Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • Delaware
THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of June 26, 2013 (the “Effective Date”) between SILICON VALLEY BANK, a California corporation (“Bank”), and VERACYTE, INC., a Delaware corporation (“Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
VERACYTE, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT November 6, 2012Investors’ Rights Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories • Delaware
This Second Amended and Restated Investors’ Rights Agreement (the “Agreement”) is entered into as of November 6, 2012, by and among Veracyte, Inc., a Delaware corporation (the “Company”) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor.”
FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
THIS FIRST AMENDMENT TO LEASE AGREEMENT (this “First Amendment”) is made and entered into as of July 11, 2012, by and between ARE-SAN FRANCISCO NO. 17, LLC, a Delaware limited liability company (“Landlord”), and VERACYTE, INC., a Delaware corporation (“Tenant”).
April 9, 2013Co-Promotion Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
This letter (the “Amendment”), effective as of the date first indicated above (the “Amendment Date”), amends that certain Co-Promotion Agreement (the “CoPromote”) dated as of January 18, 2012 by and between Genzyme Corporation (“Genzyme”) and Veracyte, Inc. (“Veracyte”) in accordance with Section 12.11 thereto. All capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the CoPromote.
APPROVAL OF VERACYTE, INC.Pathology Services Agreement • September 20th, 2013 • Veracyte, Inc. • Services-medical laboratories
Reference is made to that certain Pathology Services Agreement (the “Contract”) dated November 12, 2010 by and among Veracyte, Inc. (“Veracyte”) and Brazos Valley Pathology, P.A. (“BVPPA”). As of May 18, 2011, Veracyte hereby consents to the assignment of the Contract from BVPPA to Thyroid Cytopathology Partners, P.A. (“TCP”) as provided in that certain Assignment of Contract dated Dec 2, 2010.
